Daniel J. Becker, Director at Pandion Therapeutics, Inc. (PAND), bought 395,432 shares at $15.12 ($6.0M) on 2020-11-19, disclosed to the SEC on 2020-11-23.
Open-market purchase of $6.0M PAND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.12 | 197,716 | $3.0M | 50.0% |
| 2 | $15.12 | 197,716 | $3.0M | 50.0% |
| Total | $15.12 avg | 395,432 | $6.0M | 100% |
| Filing → |
| DAWN | BUY | 2021-06-01 | $80K | — | Filing → |
| PAND | BUY | 2020-11-19 | $867K | — | Filing → |
| PAND | BUY | 2020-07-21 | $13.0M | — | Filing → |